Africure Pharmaceuticals (India) Private Limited, a active private limited company, was established on 21 February 2017 in Palghar, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24303MH2017PTC291491. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹2.04 M.
It upholds a compliant status. Employing 118 professional, Its leadership includes Sanskar Nawal Kumar Tated (Director), Ravi Shankar Chandrasekhar (Director), Susan Teresa Noronha (Director). Past directors included Susan Teresa Noronha. It holds ₹13.50 Cr open charges and ₹5.00 Cr settled loans. Its latest AGM occurred on 29 August 2025, with the balance sheet filed on 31 March 2025. It is based at 9-12, Dewan & Sons Industrial Area Vevoor, Palghar, Maharashtra, 401404.
U24303MH2017PTC291491
291491
21 February 2017
₹1.00 Cr
₹2.04 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Africure Pharmaceuticals (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanskar Nawal Kumar Tated | Director | 21 Feb 2017 | Current |
| Ravi Shankar Chandrasekhar | Director | 21 Feb 2017 | Current |
| Susan Teresa Noronha | Director | 26 Mar 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 16 Aug 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Africure Pharmaceuticals (India) Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 40.36% decrease. The company also saw a substantial fall in profitability, with a 134.78% decrease in profit. The company's net worth dipped by a decrease of 3.38%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Africure Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹135,000,000.00
₹50,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Jan 2020 | Hdfc Bank Limited | ₹3.50 Cr | Open |
| 17 Dec 2019 | Hdfc Bank Limited | ₹10.00 Cr | Open |
| 30 Mar 2017 | Others | ₹5.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Africure Pharmaceuticals (India) has a workforce of 118 employees as of Apr 04, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Africure Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Africure Pharmaceuticals (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Africure Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 29 Aug 2025 as per latest MCA records. was documented.
The activity Africure Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.
A charge with Hdfc Bank Limited of Rs. 10.00 Cr registered on 17 Dec 2019 with Charge ID 100312605 was modified on 13 Jun 2024. was recorded as a recent event.
Progress on Susan Teresa Noronha was appointed as a Director was appointed as a Director on 26 Mar 2021 & has been associated with this company since 4 years 8 months . was documented.
The activity A charge with Hdfc Bank Limited amounted to Rs. 3.50 Cr with Charge ID 100322129 was registered on 17 Jan 2020. was completed.
The activity A charge registered on 30 Mar 2017 via Charge ID 100089238 with Others was fully satisfied on 14 Jan 2020. was completed.
The CIN of Africure Pharmaceuticals (India) Private Limited is U24303MH2017PTC291491.
Africure Pharmaceuticals (India) Private Limited is headquartered at 9-12, Dewan & Sons Industrial Area Vevoor, Palghar, Maharashtra, 401404.
Africure Pharmaceuticals (India) Private Limited was incorporated on 21 February 2017.
The current directors of Africure Pharmaceuticals (India) Private Limited are
The primary industry of Africure Pharmaceuticals (India) Private Limited is Manufacturing.
Africure Pharmaceuticals (India) Private Limited is unlisted.
The authorized capital of Africure Pharmaceuticals (India) Private Limited is ₹1.00 Cr, and the paid-up capital is ₹2.04 M.
The compliance status of Africure Pharmaceuticals (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
_PRIVATELIMITED.webp)
Company Details
+91-XXXXXXXXXX